| Drug Drug Interaction (DDI) Between Supaglutide and Digoxin or Metformin (NCT05694221) | Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | 2023-03-20 |
| Acetazolamide in Persons With Type 1 Diabetes - Dose Finding (NCT05473364) | University of California, San Diego | 2023-03-20 |
| A Phase I Study of Hemay181 in Patients With Advanced Solid Tumors (NCT05749432) | Ganzhou Hemay Pharmaceutical Co., Ltd | 2023-03-20 |
| EXL01 in the Maintenance of Steroid-induced Clinical Response/Remission in Participants With Mild to Moderate Crohn's Disease (NCT05542355) | Exeliom Biosciences | 2023-03-20 |
| The Mass Balance Study of [14C]JT001 (NCT05802810) | Shanghai Vinnerna Biosciences Co., Ltd. | 2023-03-18 |
| Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fasting State (NCT05739851) | Dong-A ST Co., Ltd. | 2023-03-18 |
| A Phase I Study of BR108 in Hematological Malignancies (NCT06018506) | BioRay Pharmaceutical Co., Ltd. | 2023-03-18 |
| NEOadjuvant Dendritic Cell Vaccination for Ovarian Cancer (NCT05773859) | Radboud University Medical Center | 2023-03-17 |
| A Study of Carbon-14-Labelled [14C] LY3437943 in Healthy Male Participants (NCT05757531) | Eli Lilly and Company | 2023-03-17 |
| A Clinical Trial of TQB2934 for Injection in Multiple Myeloma Subjects (NCT05646758) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2023-03-17 |
| A Study to Understand the Effect of Tablet Formulation and Food on PF-06821497 in Healthy Adult Participants. (NCT05767905) | Pfizer | 2023-03-17 |
| Phamacokinetics and Safety Profiles of DA-1229_01 2.5/500mg in Healthy Subjects at Fed State (NCT05739877) | Dong-A ST Co., Ltd. | 2023-03-17 |
| Study to Evaluate Orelabrutinib Tablets in Subjects With Hepatic Impairment and Healthy Subject (NCT05684653) | Beijing InnoCare Pharma Tech Co., Ltd. | 2023-03-17 |
| HMPL-453 Food Effect and PPI Study in Healthy Volunteer Study (NCT05930119) | Hutchmed | 2023-03-17 |
| Functional Lung Avoidance Radiation Therapy Using Hyperpolarized Xenon-129 MRI (NCT05302817) | Xemed LLC | 2023-03-17 |
| A Study of LY3473329 in Participants With Impaired and Normal Renal Function (NCT05778864) | Eli Lilly and Company | 2023-03-17 |
| STTEPP: Safety, Tolerability and Dose Limiting Toxicity of Lacosamide in Patients With Painful Chronic Pancreatitis (NCT05603702) | Indiana University | 2023-03-17 |
| Study of Potential CYP3A4 Induction by INDV-2000 in Healthy Adults (NCT05694533) | Indivior Inc. | 2023-03-16 |
| Feasibility Study of Intra-Tumoral Lipopolysaccharide Immunotherapy for Intra-Abdominal Tumors (NCT05751837) | Patrick Wagner, MD, FACS | 2023-03-16 |
| Study to Assess PK, Safety and Tolerability in Healthy Subjects (NCT06380699) | Changzhou Qianhong Bio-pharma Co., Ltd. | 2023-03-16 |
| Dose-escalation of Siltuximab in Combination With Idarubicin and Cytarabine Chemotherapy in Patients With Acute Myeloblastic Leukaemia (AML) With Poor Prognosis: SILTUXILAM (NCT05697510) | Nantes University Hospital | 2023-03-16 |
| Respiratory Outcomes After Early Vitamin D Supplementation in Infants Born Extremely Preterm (NCT05615311) | University of Alabama at Birmingham | 2023-03-16 |
| Low-CArbohydrate Diet and SGLT2-INhibitOr to Achieve Moderate Ketosis in Healthy Volunteers (NCT05662865) | AdventHealth Translational Research Institute | 2023-03-16 |
| A Research Study to Compare How Much Semaglutide is Found in the Blood With Different Tablets of Oral Semaglutide in Healthy Participants (NCT05784402) | Novo Nordisk A/S | 2023-03-16 |
| Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID) (NCT05776069) | Vega Therapeutics, Inc | 2023-03-16 |
| Phase Ib/IIa Dose Escalation and Expansion Study of [²¹²Pb]Pb-ADVC001 in Metastatic Prostate Cancer (TheraPb - Phase I/II Study). (NCT05720130) | AdvanCell Pty Limited | 2023-03-15 |
| An Open-label Study of Povetacicept in Autoantibody-Associated Glomerular Diseases (NCT05732402) | Alpine Immune Sciences, Inc. | 2023-03-15 |
| A Multiple-Dose Study of Bulevirtide in Participants With Normal and Impaired Renal Function (NCT05760300) | Gilead Sciences | 2023-03-15 |
| A Study to Investigate the Pharmacokinetic Profile of ALXN2050 Modified Release Prototype Formulations and Immediate Release Reference Tablet in Healthy Adult Participants (NCT05780645) | Alexion Pharmaceuticals, Inc. | 2023-03-15 |
| A Clinical Study of Intratumoral MVR-C5252 (C5252) in Patients With Recurrent or Progressive Glioblastoma (NCT05095441) | ImmVira Pharma Co. Ltd | 2023-03-15 |
| Study of Bulevirtide in Participants Who Have Normal or Impaired Liver Function (NCT05765344) | Gilead Sciences | 2023-03-15 |
| Effect of Stellate Ganglion Block on ME/CFS (NCT05664711) | Neuroversion, Inc. | 2023-03-15 |
| Safety and Tolerability of JSKN003 in Chinese Subjects With Advanced Solid Tumors (NCT05744427) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2023-03-15 |
| Study of Single Oral Doses of HOPO 14-1 Evaluating Safety, Tolerability, Pharmacokinetics (NCT05628961) | SRI International | 2023-03-15 |
| Study Investigating the Association of NP137 With Atezolizumab-Bevacizumab Combination in First Line in Unresectable HCC (NCT05546879) | University Hospital, Grenoble | 2023-03-15 |
| Spevatamig (PT886) as Monotherapy or in Combination With Chemo and/or ICI, for the Treatment of Patients With Advanced Gastric, Gastroesophageal Junction, Pancreatic Ductal or Biliary Tract Carcinomas (the TWINPEAK Study) (NCT05482893) | Phanes Therapeutics | 2023-03-15 |
| Bioequivalence Study to Compare Two Injection Devices for BMN 111 in Healthy Participants (NCT05813314) | BioMarin Pharmaceutical | 2023-03-15 |
| Thorough QT/QTc Study to Evaluate the Effects of Ecopipam (EBS-101) on Cardiac Repolarization (NCT05841160) | Emalex Biosciences Inc. | 2023-03-15 |
| A Clinical Study to Evaluate the Safety, Tolerability and Efficacy of IOS-1002 Administered Alone and in Combination With Pembrolizumab, a PD-1 Monoclonal Antibody in Advanced Solid Tumors (NCT05763004) | ImmunOs Therapeutics AG | 2023-03-15 |
| Curcumin VS Photo-bio-modulation Therapy of Oral Mucositis in Pediatric Patients Undergoing Anti-Cancer Non-invasive Treatment (NCT06044142) | Riyadh Elm University | 2023-03-15 |
| Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of Persistence (NCT05310591) | Assistance Publique - Hôpitaux de Paris | 2023-03-15 |
| A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody (NCT05662397) | HotSpot Therapeutics, Inc | 2023-03-15 |
| Safety and Immunogenicity of CVI-VZV-001 for Prevention of Herpes Zoster in Healthy Adults Age 50 Years and Above (NCT06137755) | Aribio Lab Co., Ltd. | 2023-03-15 |
| A First-In-Human Trial of pTTL in Advanced Colorectal Cancer (NCT05908643) | Neogap Therapeutics AB | 2023-03-15 |
| Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001) (NCT05721222) | Genmab | 2023-03-15 |
| Influence of Oxycodone on Individuals Taking an SSRI (NCT05730062) | Leiden University Medical Center | 2023-03-15 |
| A Phase 1b Study of Imvotamab in Moderate to Severe Rheumatoid Arthritis (NCT06087406) | IGM Biosciences, Inc. | 2023-03-15 |
| A Study of Bi-Ligand-Drug Conjugate CBP-1019 in Patients With Advanced Solid Tumors (NCT05830097) | Coherent Biopharma (Hefei) Co., Ltd. | 2023-03-14 |
| A Study of Vorasidenib in Participants With Moderate or Mild Hepatic Impairment and Matched Participants With Normal Hepatic Function (NCT05674474) | Institut de Recherches Internationales Servier | 2023-03-14 |
| Depth of Botulinum Neurotoxin Injection for Treatment of Glabellar Lines (NCT05766683) | Henry Ford Health System | 2023-03-14 |
| A Study of PYX-201 in Advanced Solid Tumors (NCT05720117) | Pyxis Oncology, Inc | 2023-03-14 |
| Phase I Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) (WSK-V102) (NCT05765604) | WestVac Biopharma Co., Ltd. | 2023-03-14 |
| Different Targeted Antibody-drug Conjugates For HER2 Ultra-low or No Expression Advanced Breast Cancer（GALAXY） (NCT05824325) | Fudan University | 2023-03-14 |
| A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors (NCT05706129) | Lumara Bio Oncologics GmbH | 2023-03-14 |
| A Study to Evaluate Plasma Gelsolin in Healthy Volunteers (NCT05789745) | BioAegis Therapeutics Inc. | 2023-03-14 |
| Safety and Immunogenicity of Recombinant Varicella Zoster Virus Vaccine in People With HIV Who Have a CD4 Count Less Than 300 or Greater Than or Equal to 300 and a Healthy Control Population (NCT05580458) | National Institute of Allergy and Infectious Diseases (NIAID) | 2023-03-13 |
| AMIC Compared With Microfracture for Focal Articular Cartilage Damage of the Hip (NCT05402072) | McMaster University | 2023-03-13 |
| A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of K-757 and K-833 in Overweight/Obese Patients With Type 2 Diabetes (NCT05890950) | Kallyope Inc. | 2023-03-13 |
| An Open-Label Exploratory Study of Fosigotifator in Participants With Vanishing White Matter Disease (NCT05757141) | Calico Life Sciences LLC | 2023-03-13 |
| A Study of ASP1002 in Adults for Treatment of Solid Tumors (NCT05719558) | Astellas Pharma Global Development, Inc. | 2023-03-13 |
| A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors (NCT05795595) | CRISPR Therapeutics AG | 2023-03-13 |
| A Study to Evaluate the Safety, Pharmacokinetics and Preliminary Efficacy of APG-5918. (NCT05773586) | Ascentage Pharma Group Inc. | 2023-03-13 |
| Innate Immunity Stimulation Via TLR9 in Early AD (NCT05606341) | NYU Langone Health | 2023-03-13 |
| A PK Study Testing Single Oral Dose of Elacestrant in Subjects With Normal or Severely Impaired Hepatic Function (NCT06126575) | Stemline Therapeutics, Inc. | 2023-03-13 |
| Writing About Experiences and Health in Older Adults II (NCT05524597) | University of California, Los Angeles | 2023-03-13 |
| Study Evaluating the Safety, Tolerability, and Efficacy of FLT3 CAR-T AMG 553 in FLT3-positive Relapsed/Refractory AML (NCT03904069) | Amgen | 2023-03-13 |
| A Phase 1 Bioequivalence Study of Efgartigimod PH20 SC Administered Via a Prefilled Syringe Versus a Vial+Syringe Presentation in Healthy Adults (NCT05817435) | argenx | 2023-03-13 |
| A Study to Assess the Safety and Pharmacokinetics of AD-104-A (NCT05703282) | Addpharma Inc. | 2023-03-13 |
| Study of LQT-1213 on QTc-induced Prolongation in Healthy Adult Subjects (Part1) and on Congenital Long QT in Patients Diagnosed With Type 2 or 3 Long QT Syndrome (Part 2). (NCT05906732) | Thryv Therapeutics, Inc. | 2023-03-12 |
| Study to Compare the Pharmacokinetics and Pharmacodynamics of ASA Powder for Oral Inhalation With Non-enteric-coated Chewable Aspirin in Adult Subjects With Obstructive or Restrictive Pulmonary Function (NCT05625347) | Vectura, Inc. | 2023-03-11 |
| Clinical Trial of Recombinant Pneumococcal Protein Vaccine (NCT05622942) | CanSino Biologics Inc. | 2023-03-11 |
| A Clinical Study to Evaluate the Safety and the Pharmacokinetics of UI068 in Healthy Adult Volunteers Under Fed Conditions (NCT06141590) | Korea United Pharm. Inc. | 2023-03-11 |
| Study of TU2218 in Combination With KEYTRUDA®(Pembrolizumab) in Patients With Advanced Solid Tumors (NCT05784688) | TiumBio Co., Ltd. | 2023-03-10 |
| A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies (NCT05643742) | CRISPR Therapeutics AG | 2023-03-10 |
| A Study of MK-2225 / ACE-1334 in Participants With Systemic Sclerosis With and Without Interstitial Lung Disease (MK-2225-002) (NCT04948554) | Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA | 2023-03-10 |
| To Evaluate the PK, PD, Safety and Drug Tolerance of JW0302 in Healthy Volunteers (NCT05784155) | JW Pharmaceutical | 2023-03-10 |
| Clinical Trial of CD40L-Augmented TIL for Patients With EGFR, ALK, ROS1 or HER2-Driven NSCLC (NCT05681780) | H. Lee Moffitt Cancer Center and Research Institute | 2023-03-10 |
| A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM (NCT05761301) | Alnylam Pharmaceuticals | 2023-03-10 |
| Capeox Regimen Combined With Sintilimab and Bevacizumab for Gastric Cancer (NCT05640609) | West China Hospital | 2023-03-10 |
| Single Ascending Dose Study of 9MW3011 in Chinese Healthy Subject (NCT06389942) | Mabwell (Shanghai) Bioscience Co., Ltd. | 2023-03-10 |
| A Study to Evaluate the Safety, Tolerability and Drug Levels of BMS-986447 in Healthy Participants (NCT05760937) | Bristol-Myers Squibb | 2023-03-10 |
| OMAR Opioid Use Disorder (NCT05683184) | Yale University | 2023-03-10 |
| A Study of IBI351 in Healthy Subjects (NCT05699993) | Innovent Biologics (Suzhou) Co. Ltd. | 2023-03-10 |
| A Study to Evaluate the Metabolism, Excretion, and Mass Balance of [¹⁴C]Enlicitide Chloride ([¹⁴C]MK-0616) in Healthy Participants (MK-0616-016) (NCT06658626) | Merck Sharp & Dohme LLC | 2023-03-10 |
| Mesothelin/GPC3/GUCY2C-CAR-T Cells Against Cancers (NCT05779917) | Second Affiliated Hospital of Guangzhou Medical University | 2023-03-10 |
| IBI310 in Combination With Sintilimab in Patients With Advanced Biliary Tract Cancer (NCT05653180) | Innovent Biologics (Suzhou) Co. Ltd. | 2023-03-10 |
| A Phase 1 Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine (NCT06113744) | CNBG-Virogin Biotech (Shanghai) Ltd. | 2023-03-10 |
| Phase 1 Clinical Trial of RHN-001 in Healthy Adult Volunteers (NCT05847218) | RH Nanopharmaceuticals | 2023-03-09 |
| To Evaluate the Effect of Food on the Safety and PK Characteristics of DWP16001 in Healthy Adult Volunteers (NCT05797922) | Daewoong Pharmaceutical Co. LTD. | 2023-03-09 |
| Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas (NCT05210374) | Case Comprehensive Cancer Center | 2023-03-09 |
| The Study of ICP-248 in Patients With Mature B-cell Malignancies (NCT05728658) | Beijing InnoCare Pharma Tech Co., Ltd. | 2023-03-09 |
| A Study of BLB-201 RSV Vaccine in Infants and Children (NCT05655182) | Blue Lake Biotechnology Inc. | 2023-03-09 |
| A Study to Examine Respiratory Combination Vaccines Against Respiratory Syncytial Virus (RSV) and Flu in Older Adults (NCT05788237) | Pfizer | 2023-03-09 |
| Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers (NCT05735496) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2023-03-09 |
| A Study to Assess the Effect of AZD0780 on the Pharmacokinetics of Rosuvastatin. (NCT05787002) | AstraZeneca | 2023-03-09 |
| Multiple Ascending Dose Study of CG200745 'Ivaltinostat' Oral Capsule (NCT05716919) | Machaon Biotherapeutics, Inc. | 2023-03-09 |
| Trial to Demonstrate the Equivalence of Two Different Strengths of Oral Centanafadine Capsules in Healthy Subjects (NCT07486895) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2023-03-08 |
| A Safety and Antitumor Activity Trial of Immunoradiotherapy Combinations as a Treatment Option for Subjects With Metastatic Solid Tumors (NCT05491317) | Genmab | 2023-03-08 |
| Tafasitamab (MOR00208) in Pediatric Patients With Relapsed or Refractory Acute B Lineage Leukemia (NCT05366218) | University Hospital Tuebingen | 2023-03-08 |
| To Evaluate a Phase Ia/Ib Clinical Study of EG017 in Patients With Advanced Breast Cancer. (NCT05673694) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2023-03-08 |